small molecule HCV fusion inhibitors (Fuzians)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule HCV fusion inhibitors (Fuzians)
Drug Alias Namesmall molecule HCV fusion inhibitors (University of Alabama)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus uptake inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuzians Biomedicals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A